Fintech start-up SoFi says it will merge with a special purpose acquisition company, or SPAC, backed by venture capital investor Chamath Palihapitiya.
The stock market is looking past DC turmoil and keeps going higher. Here’s why
Despite the chaos at the Capitol, the S&P 500 closed Wednesday at a new high, which baffled some observers.
NYSE will delist three big China telecoms, reversing decision once again
The NYSE said its second reversal in two days came after new guidance from the Treasury Department.
Stocks making the biggest moves in the premarket: Tesla, Micron Technology, Sarepta Therapeutics & more
The stocks making the biggest moves in premarket trading include Tesla, Micron Technology, Sarepta Therapeutics & more.
How concerned investors should be about Biden’s tax proposals
The Democrat’s control of Congress has shone a new spotlight on Biden’s tax proposals, particularly those that would affect stocks and bonds.
Bitcoin’s wild rally — and a fear of missing out — has retail investors flocking to crypto
New investors are rushing to capture some of the wild gains in the cryptocurrency market.
China’s major telcos in Hong Kong take a beating ahead of Trump’s investment ban
Stock index giants MSCI and FTSE Russell said they would remove three Chinese telecommunications giants‘ Hong Kong-traded shares from widely followed indexes.
American Express shares dip on report that federal investigators are probing sales practices
American Express said Thursday in a statement that it has „robust compliance policies and controls in place, and do not tolerate misconduct.“
Victoria’s Secret parent L Brands says holiday same-store sales rose 5%, offers upbeat profit outlook
L Brands said its same-store sales during the holiday period were up 5%, compared with a 3% drop a year earlier.
UK reportedly set to approve use of Moderna vaccine as soon as today
Bloomberg reports on the matter
The report cites people familiar with the Moderna approval process, in saying that the UK is reviewing the vaccine on an accelerated timetable and are poised to authorise it for emergency use as soon as Friday.
The report cites people familiar with the Moderna approval process, in saying that the UK is reviewing the vaccine on an accelerated timetable and are poised to authorise it for emergency use as soon as Friday.